About 50 results
Open links in new tab
  1. Encoded Therapeutics – Translating Next-Generation Science into ...

    Translating Next-Generation Science Into Transformative Gene TherapiesLearn About Our Programs

  2. Contract People Operations Manager – Encoded Therapeutics

    Encoded Therapeutics Inc. is a biotechnology company advancing precision medicines for a broad range of genetic disorders. Our mission is to unlock new opportunities for viral gene …

  3. 2019 2020 2021 Encoded founded by Kartik Ramamoorthi and Stephanie Tagliatela Developed foundation for genomics-based platform technology Established preclinical proof of concept …

  4. Research Areas – Encoded Therapeutics

    Each one of our programs is born at Encoded as a solution to a biological problem. We combine genomics-driven data with internal biological expertise and access to worldwide thought …

  5. Axon 1 Mutation in a single copy of the 6kb SCN1A gene, which codes for the voltage-gated sodium channel Na V1.1 (haploinsu ciency).

  6. Kartik Ramamoorthi, Ph.D. – Encoded Therapeutics

    Kartik Ramamoorthi, Ph.D., is co-founder, chief executive officer and member of the board of directors at Encoded Therapeutics.

  7. Genetic Medicines Product Engine – Encoded Therapeutics

    Encoded is independently building a pipeline of potentially best- and first-in-class therapies focused on central nervous system (CNS) disorders. Our research platform is internally …

  8. Finn’s Story – Encoded Therapeutics

    By providing your information, you agree to allow Encoded Therapeutics to collect the name and email address provided and to be contacted by Encoded and its partners using this information.

  9. Karan Takhar – Encoded Therapeutics

    Karan Takhar is a member of the board of directors at Encoded Therapeutics and serves as Managing Director at Matrix Capital Management Company, L.P. At Matrix he leads and …

  10. Encoded Therapeutics Announces Regenerative Medicine …

    Encoded Therapeutics is a clinical-stage genetic medicines company developing potentially one-time, disease-modifying therapies for severe neurological disorders.